Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

20054,114 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 366, Issue 9493, pp. 1279-1289

Field-Weighted Citation Impact: 218.09